melanocortin peptide
News
13.07.2016
Cynosure to Ring NASDAQ Stock Market Closing Bell to Celebrate 25 Year Anniversary
Cynosure, Inc. (NASDAQ: CYNO) today announced that President and CEO Michael Davin, along with other members of the Company’s management team, will ring the Closing Bell at the NASDAQ Stock […]
21.01.2021
Asclepion Laser Technologies: Innovative partner for your aesthetic practice
To develop innovative and successful products is the ethos of Asclepion Laser Technologies. Therefore, the company invests intensively in research and medical practice. The goal is to make the advantages […]
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]

